Pfizer Inc.
SOLUBLE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (SFGFR3) POLYPEPTIDES AND USES THEREOF
Last updated:
Abstract:
The invention features soluble fibroblast growth factor receptor 3 (sFGFR3) polypeptides. The invention also features methods of using sFGFR3 polypeptides to treat skeletal growth regardation disorders, such as achondroplasia.
Status:
Application
Type:
Utility
Filling date:
20 Apr 2021
Issue date:
7 Oct 2021